Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 46 | $77,547,686 |
Sells | 105 | $271,574,864 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 18 Apr 2024 | Sale | 2,623 | 14.06 | 36,879 | I |
18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2024 | Sale | 300 | 14.15 | 4,245 | I |
18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 16 Apr 2024 | Sale | 14,069 | 14.01 | 197,107 | I |
15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2024 | Sale | 461,899 | 14.49 | 6,692,917 | I |
15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2024 | Sale | 23,101 | 14.42 | 333,116 | I |
18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 18 Sep 2024 | Sale | 25,631 | 0.73 | 18,711 | I |
18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 17 Sep 2024 | Sale | 111,400 | 0.73 | 81,322 | I |
18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 16 Sep 2024 | Sale | 63,100 | 0.74 | 46,694 | I |
29 Jun 2023 16:42 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2023 | Purchase | 575,195 | 0.84 | 483,164 | I |
29 Jun 2023 16:42 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 27 Jun 2023 | Purchase | 617,382 | 0.84 | 518,601 | I |
24 Nov 2023 16:38 | PMVP | PMV Pharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 22 Nov 2023 | Sale | 87,786 | 2.23 | 195,763 | I |
24 May 2023 17:09 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 22 May 2023 | Purchase | 869,565 | 5.75 | 4,999,999 | I |
15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 21,658 | 4 | 86,632 | I |
15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 478,342 | 4 | 1,913,368 | I |
29 Nov 2022 16:36 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 25 Nov 2022 | Purchase | 762,380 | 5.25 | 4,002,495 | I |
28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
31 Aug 2023 17:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 29 Aug 2023 | Purchase | 500,000 | 6.2 | 3,100,000 | I |
25 Nov 2022 20:13 | TCDA | Tricida Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Nov 2022 | Sale | 3,629,226 | 0.22 | 798,430 | I |
25 Nov 2022 20:13 | TCDA | Tricida Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Nov 2022 | Sale | 5,617,300 | 0.21 | 1,179,633 | I |
25 Nov 2022 20:13 | TCDA | Tricida Inc | ORBIMED ADVISORS LLC | Director , 10% | 22 Nov 2022 | Sale | 1,034,421 | 0.22 | 227,573 | I |
02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 02 Jul 2024 | Sale | 36,600 | 4.54 | 166,164 | I |
02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 01 Jul 2024 | Sale | 13,700 | 4.68 | 64,116 | I |
02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2024 | Sale | 378,000 | 4.74 | 1,791,720 | I |
21 Apr 2023 17:08 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 21 Apr 2023 | Sale | 27,700 | 9.41 | 260,657 | I |
21 Apr 2023 17:08 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 20 Apr 2023 | Sale | 28,300 | 9.43 | 266,869 | I |
21 Apr 2023 17:08 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 19 Apr 2023 | Sale | 136,000 | 9.3 | 1,264,800 | I |
17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 623 | 10 | 6,230 | I |
17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 556 | 10 | 5,560 | I |
17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 4,009 | 10 | 40,090 | I |
17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 6,142 | 10 | 61,420 | I |
17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 5,401 | 10 | 54,010 | I |
17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 39,433 | 10 | 394,330 | I |
28 Dec 2022 17:57 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Dec 2022 | Purchase | 137,931 | 7.25 | 1,000,000 | I |
21 Sep 2022 18:00 | THRD | Third Harmonic Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 19 Sep 2022 | Purchase | 300,000 | 17 | 5,100,000 | I |
19 Jul 2023 16:15 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 17 Jul 2023 | Purchase | 151,450 | 3.05 | 461,922 | I |
19 Jul 2023 16:15 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 17 Jul 2023 | Purchase | 328,482 | 3.05 | 1,001,870 | I |
09 Nov 2022 16:25 | THRX | Theseus Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 07 Nov 2022 | Purchase | 192,000 | 5.21 | 1,000,320 | I |
24 Jul 2023 16:38 | TSBX | Turnstone Biologics Corp | ORBIMED ADVISORS LLC | Director , 10% | 20 Jul 2023 | Purchase | 416,666 | 12 | 4,999,992 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 14,400 | 21.96 | 316,224 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 92,992 | 24.11 | 2,242,037 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 1,116,048 | 23.23 | 25,925,795 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 961,328 | 22.27 | 21,408,775 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 22 Dec 2022 | Sale | 684,696 | 22.07 | 15,111,241 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 22 Dec 2022 | Sale | 3,284,800 | 21.71 | 71,313,008 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)